Richard Carvajal on Immunotherapy Dosing

Video

Richard Carvajal, MD, discusses how to make decisions regarding the dosing limits of immunotherapy agents.

Richard Carvajal, MD, from Columbia University Medical Center discusses deciding on dosing limits for immunotherapy treatments.

The proper dosing for immunotherapy efficacy is unclear. For chemotherapy, the patients can often be pushed to toxicity. However, with immunotherapies and targeted therapies, there are responses seen after 1 or 2 doses. There are also durable responses in some patients if treatment is stopped.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with shoulder-length hair wearing a blue blouse